Form 4: Silicon Laboratories CEO Robert Johnson Sells Shares Under 10b5-1 Trading Plan

Silicon Laboratories CEO Robert Matthew Johnson sold 7,230 shares of common stock on June 3, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On June 3, 2024, Robert Matthew Johnson, the President and CEO of Silicon Laboratories Inc. (SLAB), sold 7,230 shares of the company's common stock.
• The sale was executed under a 10b5-1 trading plan.
• The price per share ranged from $122.36 to $127.08, with a weighted average selling price of $123.8.
• Following the transaction, Johnson directly owns 47,910 shares of Silicon Laboratories Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan and doesn't necessarily reflect a change in the executive's outlook on the company.

Industry Context

Executive stock sales are a common occurrence, and sales under 10b5-1 plans are often viewed as less impactful since they are pre-arranged. Investors often monitor these filings for insights into management's perspective on the company's valuation and future prospects. It is important to note that this is a small percentage of the overall holdings.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder sentiment, but the pre-planned nature of the transaction mitigates potential concerns.

Key Dates